Ultrasound/microbubble (US/MB)-mediated drug delivery is a promising approach to effectively deliver therapeutic agents to target tumors by increasing vascular permeability through sonoporation. Equipped with focused ultrasound, drug delivery platforms can increase site-specificity. To move toward clinical translation, such a platform requires both image guidance for accurate location of tumor targets and quantitative mapping of the therapeutic dose for effective treatment.
展开▼
